Patent · US Active

Enhanced influenza hemagglutinin binders

US9771395B2 · kind B2 · utility

0Cited by
5References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2015
Grant dateSep 26, 2017
Priority date
Expiry dateMar 20, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Designed polypeptides having the amino acid sequence of SEQ ID NQ: 1 are described that bind with high affinity and selectivity to the influenza hemagglutinin protein, and which can be used for treating and/or limiting an influenza infection, as well as diagnosing an influenza infection and identifying candidate compounds for treating an influenza infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.